CAS RN: 331465-71-5
2,8,9-Tri-i-butyl-2,5,8,9-tetraaza-1-phosphabicyclo[3.3.3]undecane
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 5g
Available purity: ≥97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 331465-71-5
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
5g
≥97%
0
Out of Stock
Beijing
Inquiry
331465-71-5 / 2,8,9-tris(2-methylpropyl)-2,5,8,9-tetraza-1-phosphabicyclo[3.3.3]undecane
Standard CAS: 331465-71-5
Multi CAS: Yes
Basic Information
copy
CAS
331465-71-5 copy
Multi CAS
Yes copy
Molecular Formula
C18H39N4P copy
Molecular Weight
342.500000 copy
Exact Mass
342.291234 copy
InChI
InChI=1S/C18H39N4P/c1-16(2)13-20-10-7-19-8-11-21(14-17(3)4)23(20)22(12-9-19)15-18(5)6/h16-18H,7-15H2,1-6H3 copy
InChIKey
WFHPXSHLCFHEIA-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
23 copy
Fraction Csp3
1 copy
Rotatable bonds
6 copy
H-bond acceptors
4 copy
Molar refractivity
102.59 copy
TPSA
12.96 copy
LogP / Solubility
WLOGP
3.42 copy
MLOGP
3.02 copy
XLogP3
4.2 copy
Consensus LogP
3.55 copy
Log S (ESOL)
-3.72 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-4.84 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-5.44 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
Yes copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.38 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
Yes copy
Synthetic Accessibility
4.5 copy